Outpatient Respiratory Syncytial Virus Infections and Novel Preventive Interventions

• 2024

  Sign in to bookmark this resource.

  Sign in
• Sarah Hak; Roderick Venekamp; Joanne Wildenbeest; Louis Bont
PMID: 38085019DOI: https://dx.doi.org/10.1097/MOP.0000000000001323

---

Access Resources

• Journal ArticleEN

About

This article focuses on respiratory syncytial virus (RSV) infections that occur outside of hospitals. It describes new ways to prevent these infections, which are common in children and can cause serious breathing problems. The article highlights the importance of early detection and prevention methods like vaccines and other treatments. By using these new interventions, it aims to reduce the number of RSV cases and help keep people healthier, especially during peak seasons when RSV is more common.

---

Tags

Hazard: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Niresivemab Library

Keywords: Antiviral Agents; Delivery of Health Care; Immunization; Infant; Maternal Health; Outpatients; Pregnant Women; Preventive Health Services; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines

Institutions: University Medical Center Utrecht; Respiratory Syncytial Virus NETwork (ReSViNET) Foundation

---

More like this

The Respiratory Syncytial Virus Vaccine and Monoclonal Antibody Landscape: The Road to Global Access 2024 · University Medical Center Utrecht, Yenepoya University, University of Edinburgh, National Institutes of Health (NIH), London School of Hygiene and Tropical Medicine Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson has not been Learnt 2023 · Hôpital Antoine-Béclère AP-HP, Université Paris-Saclay, American College of Emergency Physicians, Hospital General Universitario Gregorio Marañón, St. Marien Children's Hospital, University Medical Centre Utrecht, Respiratory Syncytial Virus NETwork (ReSViNET) Foundation, University Hospital of Padova Nirsevimab Binding-Site Conservation in Respiratory Syncytial Virus Fusion Glycoprotein Worldwide Between 1956 and 2021: An Analysis of Observational Study Sequencing Data 2023 · AstraZeneca, University Medical Center Utrecht

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---